DocWire News Editors

DocwireNews

Filipino patients with chronic myeloid leukemia (CML) exhibited positive health-related quality of life (HRQoL) using newer-generation tyrosine kinase inhibitors (TKIs) as second or third-line therapy, according to a study presented at the 12th International Congress on Myeloproliferative Neoplasms.&nbsp;This single-center, cross-sectional study included 33 chronic-phase CML patients who were at least 19 years old with stable comorbidities, taking newer-generation-TKIs as second-or-third line treatment. The newer-generation TKIs used in this study were Dasatinib (54.55%), Bosutinib (30.30%) and Ponatinib (15.15%). The researchers assessed HRQoL using the Filipino-version of the FACT-Leu&copy; questionnaire. They employed descriptive statistics to analyze each patients&rsquo; demographic and clinical characteristics. To test for any variances, they used an independent sample T-test and one-way analysis of variance.According to the results of the study, the following displayed favorable HRQoL scores on average: Trial Outcomes Index (106.15 + 12.27), FACT-G score (94.79 + 10.74) and FACT-Leu score (151.58 + 17.25). The researchers noted that they observed no significant differences between HRQOL with sex, marital status, educational attainment, employment, adverse drug events with concomitant dose adjustment and newer-generation TKI used. They also found insufficient evidence to conclude a correlation between overall FACT-Leu score and age, CML and treatment duration (p-value 0.7389, 0.4738, 0.6984).&ldquo;HRQoL evaluation is a vital part of disease management,&rdquo; the research authors wrote in their conclusion. &ldquo;This study demonstrated that Filipino CML patients using newer-generation TKIs as second or third-line therapy showed good HRQoL regardless of age, sex, marital status, educational attainment, employment, CML duration, treatment duration, presence or absence of adverse drug event with concomitant dose adjustment and newer-generation TKI used.&rdquo;Tanchanco C, et al. Health-Related Quality of Life of Chronic Myeloid Leukemia Patients on Newer Generation Tyrosine Kinase Inhibitors Using the Filipino Version of the Functional Assessment of Cancer Therapy &ndash; Leukemia (FACT-LEU) Tool at the Philippine General Hospital. Presented at the 12th International Congress on Myeloproliferative Neoplasms; October 24-25, 2019; New York, NY.

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Health-Related Quality of Life of Chronic Myeloid Leukemia Patients on Newer Generation Tyrosine Kinase Inhibitors Using the Filipino Version of the Functional Assessment of Cancer Therapy: The Leukemia (FACT-LEU) Tool

MPN Conference Coverage 2019

Filipino patients with chronic myeloid leukemia (CML) exhibited positive health-related quality of life (HRQoL) using newer-generation tyrosine kinase inhibitors (TKIs) as ...

Health-Related Quality of Life of Chronic Myeloid Leukemia Patients on Newer Generation Tyrosine

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe